Douglas Joseph Hirsch - 03 Jun 2025 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Role
Director
Signature
/s/ Gracye Cheng, Attorney-in-Fact for Douglas Joseph Hirsch
Issuer symbol
GDRX
Transactions as of
03 Jun 2025
Transactions value $
$0
Form type
4
Filing time
04 Jun 2025, 18:49:48 UTC
Previous filing
03 Jan 2025
Next filing
27 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hirsch Douglas Joseph Director C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA /s/ Gracye Cheng, Attorney-in-Fact for Douglas Joseph Hirsch 04 Jun 2025 0001822522

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GDRX Class A Common Stock Award $0 +57.1K +36.96% $0.00 211K 03 Jun 2025 Direct F1
holding GDRX Class A Common Stock 2.63M 03 Jun 2025 By CH 2024-2 GRAT F2
holding GDRX Class A Common Stock 2.63M 03 Jun 2025 By DH 2024-2 GRAT F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units vest in full on the earlier of (i) the one-year anniversary of June 3, 2025 and (ii) the date of the 2026 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2028; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).
F2 Share held directly by CH 2024-2 GRAT, a grantor retained annuity trust (the "CH 2024-2 GRAT"). Chona Hirsch, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the CH 2024-2 GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the CH 2024-2 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares.
F3 Share held directly by DH 2024 -2 GRAT, a grantor retained annuity trust (the "DH 2024-2 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the DH 2024-2 GRAT.